General Information

Location: Washington, DC

Organization: Statistics Collaborative

Job Type: Full Time - Regular

Description and Requirements

Our biostatisticians are integral parts of teams. They collaborate with external clients on studies involving new drugs, biologics, devices, and vaccines, as well as behavioral interventions across a range of disease areas.


-Writing descriptions of methods and analyses in protocols, statistical analysis plans, data monitoring committee reports, manuscripts, and clinical study reports

-Analyzing clinical data

-Performing statistical programming

-Contributing to the quality assurance of statistical analyses

-Communicating with clients and other external parties

-Organizing and maintaining confidential project materials


-Master’s degree or Ph.D. in Biostatistics or Statistics, or Master’s degree or Ph.D. in epidemiology with considerable coursework in Biostatistics

-Knowledge of applied statistical methodology

-5+ years experience working as a prior Biostatistician

We are especially interested in candidates who have the following skills:

-Knowledge of base SAS, SAS macro language, SAS graphics, and SAS/STAT or facility with R

-Experience using SAS or other statistical software to report results of clinical trials or other type of studies

-Attention to detail, accuracy, initiative, excellent written and oral communication skills, and scientific curiosity are essential, as well as the ability to juggle several complex projects simultaneously.

Materials to submit: 
To apply, please submit a cover letter (include Ref: STBS), résumé, SAS or R programming sample, writing sample, and undergraduate and graduate transcripts through the form below. We only consider applicants who have submitted all required documents.


To be considered for U.S.-based positions unless currently employed by WCG, where permitted by applicable law (including any applicable reasonable accommodation, medical or religious exemption), candidates must have received or be willing to receive the COVID-19 vaccine by start date.